FierceBiotech Announces Annual "Fierce 15" Winners

WASHINGTON, DC - September 15, 2010 - FierceBiotech (www.fiercebiotech.com) announced today its annual "Fierce 15" list of the top privately held biotech companies of 2010. FierceBiotech Editor-in-Chief, John Carroll, chose this year's winners based on their promise as quick upstarts and their collectively ambitious plans to create and quickly advance significant projects. This year’s winners represent a diverse group-from small start-ups, to larger operations that have been in business for over a decade.

An internationally recognized daily newsletter reaching more than 78,000 biotech and pharma industry professionals, FierceBiotech provides subscribers with a quick authoritative briefing on the day's top stories, with a special focus on drug discovery and clinical trials.

"The Fierce 15 award-now being awarded for the eighth consecutive year-is renowned in the biotech industry for spotlighting the achievements of companies who step outside the box," said Carroll. "Each of this year's winners offers us a lesson on what it takes to create success in the drug development field."

The "Fierce 15" celebrates the spirit of being "fierce" - championing innovation and creativity, even in the face of intense competition. A profile of each of the "Fierce 15" companies is available on the FierceBiotech Web site at http://www.fiercebiotech.com/story/2010-fierce-15/2010-09-15.

The 2010 Fierce 15 winners are: ?

1. Acceleron Pharma

2. Adimab

3. Alder Biopharmaceuticals

4. Amira Pharmaceuticals

5. Anchor Therapeutics

6. Avila Therapeutics

7. Catabasis Pharmaceuticals

8. Dicerna Pharmaceuticals

9. Eleven Biotherapeutics

10. Gelesis

11. iPierian

12. Kymab

13. Plexxikon

14. Tetraphase Pharmaceuticals

15. VentiRx Pharmaceuticals

In addition to the editorially selected winners, this year FierceBiotech also introduced a Reader’s Choice award. Based on reader submissions, the publication included Gelesis among the ranks of the companies recognized.

About FierceBiotech

FierceBiotech is the biotech industry's daily monitor - a free email newsletter and web resource providing the latest biotech news, articles, and resources related to clinical trials, drug discovery, FDA approval, FDA regulation, patent news, pharma news, biotech company news, and more. More than 78,000 top biotech professionals rely on FierceBiotech for an insider briefing on the day's top stories. Sign up is free at http://www.fiercebiotech.com.

About FierceMarkets

FierceMarkets, a leader in B2B e-media, provides information and marketing services in the Telecommunications, Life Sciences, Healthcare, IT, and Finance industries through its portfolio of e-mail newsletters, Web sites, webinars, and live events. Every business day, FierceMarkets' wide array of publications reaches more than 985,000 executives in over 100 countries. Current publications include: Telecom: FierceBroadbandWireless; FierceDeveloper; FierceCable; FierceIPTV; FierceMobileContent; FierceTelecom; FierceOnlineVideo; FierceVoIP; FierceWireless; FierceWireless:Europe. Healthcare: FierceEMR; FierceHealthcare; FierceHealthIT; FierceHealthFinance; FierceHealthPayer; FierceMobileHealthcare; Hospital Impact. Life Sciences: FierceBiotech; FierceBiotech Research; FierceBiotechIT; FierceMedicalDevices; FierceDrugDelivery; FiercePharma; FiercePharma Manufacturing; FierceVaccines. Enterprise IT: FierceCIO; FierceCIO:TechWatch; FierceContentManagement; FierceGovernmentIT; FierceMobileIT. Finance: FierceComplianceIT; FierceFinance; FierceFinanceIT.